共 50 条
- [38] Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or vedolizumab: a retrospective study ANNALS OF GASTROENTEROLOGY, 2023, 36 (04): : 430 - 436